CompletedPhase 1NCT00908466
Sirolimus as Therapeutic Approach to Uveitis
Studying Infectious panuveitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Johns Hopkins University
- Principal Investigator
- Quan D Nguyen, MD, MScJohns Hopkins University
- Intervention
- Sirolimus (rapamycin)(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2013
Study locations (1)
- Wilmer Eye Institute at Johns Hopkins University, Baltimore, Maryland, United States
Collaborators
MacuSight, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00908466 on ClinicalTrials.gov